![Jay Kleiman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Kleiman
No más puestos en curso
Health Technology
Perfil
Jay Kleiman is Vice President of Northfield Laboratories, Inc. He was Chief Medical Officer and Head of Cardiovascular Development for Vasogen, Inc.
Antiguos cargos conocidos de Jay Kleiman.
| Empresas | Cargo | Fin |
|---|---|---|
Northfield Laboratories, Inc.
 Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Corporate Officer/Principal | 10/11/2009 |
Vasogen, Inc.
 Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Health Technology |
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Health Technology |
- Bolsa de valores
- Insiders
- Jay Kleiman
